The Centers for Medicare and Medicaid Services (CMS) has released a summary of each HCPCS Level II code application decision. The document is twenty-eight pages long and the link can be found in the Resources section.
There are 23 items included in the Second Quarter 2024 Drug and Biological decisions. Twenty new codes have been established. There is one title revision and two code deletions.
| Title | Decision | HCPCS Code | Description |
| Docivyx | Title Revision | J9172 | Change manufacturer from Ingenus to Avyxa |
| Xenoview™ | Add | A9610 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| Delete | J9150 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose | |
| Aurlumyn™ | Add | J1749 | Inj, iloprost, 0.1mcg |
| Combogesic ® | Add | J0138 | Inj, acetaminophen 10 mg and ibuprofen 3 mg |
| Paclitaxol Protein Bound Particles | Delete | J9258 | Inj, paclitaxel protein-bound particles (teva) not therapeutically equivalent to J9264, 1 mg. |
| Jubbonti & Wyost | Add | Q5136 | Inj, denosumab-bbdz, biosimilar, 1 mg |
| TYENNE ® | Add | Q5135 | Inj, tocilizumab-aazg, biosimilar, 1 mg |
| TEVIMBRA | Add | Q9329 | Inj, tislelizumab-jsgr, 1 mg |
| KISUNLA™ | Add | J0175 | Inj, donanemab-azbt, 2 mg |
| Baxter’s Vasopressin in Sodium Chloride | Add | J2601 | Inj, vasopressin (baxter), 1 unit |
| Tri-Membrane Wrap | Add | Q4344 | Tri-membrane wrap, per square centimeter |
| Dermacyte® AC Matrix Amniotic Membrane Allograph | Add | Q4343 | Dermatocyte ac matrix amniotic membrane allograph, per square centimeter |
| TheraMend | Add | Q4342 | Theramend, per square centimeter |
| Matrix HD Allograft Dermis | Add | Q4345 | Matrix hd allograft dermis, per square centimeter |
| Artacent C | Add | Q4336 | Artacent c, per square centimeter |
| Artacent Trident | Add | Q4337 | Artacent trident, per square centimeter |
| Artacent Velos | Add | Q4338 | Artacent velos, per square centimeter |
| Artacent VeriClen | Add | Q4339 | Artacent vericlen, per square centimeter |
| AmnioPlast 1 ™ | Add | Q4334 | Amnioplast 1, per square centimeter |
| AmnioPlast 2 ™ | Add | Q4335 | Amnioplast 2, per square centimeter |
| SimpliMax | Add | Q4341 | Simplimax, per square centimeter |
| SimpliGraft | Add | Q4340 | Simpligraft, per square centimeter |
It is recommended to review the application results to determine when the code becomes active or inactive.
There is also an analysis of HCPCS codes for products approved by the Food and Drug Administration (FDA) under the 505(b)(2) NDA and BLA Pathways and Products Not Otherwise Classified. The results are eight new codes, one revision, and four deletions as shown below:
The release of the application decisions means that the chargemaster coordinator must review the chargemaster to see if the changes impact the file.
Each of the added items should be discussed with the pharmacy department or chief medical officer (CMO) to determine if there is a plan to add these drugs and biologicals to the formulary. Pharmaceuticals can be difficult because of the translation that is made from the units described in the code description to the usual dosage amount.
The HCPCS codes are updated on a quarterly basis so this process should occur with each release. It is important to avoid unnecessary claim denials due to inactive codes or missed charges because the new codes are not available for reporting.
Resources:
2024-hcpcs-application-summary-quarter-2-2024-drugs-and-biologicals.pdf (cms.gov)
It finally happened! The Centers for Medicare & Medicaid Services (CMS) finally released the 2026 Outpatient Prospective Payment Final Rule on Friday at 4:15 pm,
EDITOR’S NOTE: Ritesh Ramesh, CEO for MDaudit, appeared on Monitor Monday to report his company’s findings on nationwide audit trends. The rate of payer audits
Please log in to your account to comment on this article.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
